Cognition Therapeutics Inc.

CGTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.01

+$0.01 (+1.00%)

Sep 22, 2026, 11:22 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $89.5M

Enterprise Value $56M

Beta 1.79

Average Volume 1.14M

Shares Outstanding (Diluted) 90.62M

Shares Change YoY 42.29%

Institutional Ownership 24.01%

Exchange NASDAQ

ISIN US19243B1026

Price Performance

Price Change 1M 1.0%

Price Change 3M -39.4%

Price Change 6M -9.9%

Price Change YTD -32.0%

Price Change 1Y -30.1%

Price Change 3Y -24.8%

Price Change 5Y -92.2%

1M CAGR (ann.) -7.4%

1Y CAGR (ann.) -32.0%

5Y CAGR (ann.) N/A

All-Time CAGR -40.2%

Valuation

PE Ratio -5.26

Forward PE N/A

PEG Ratio -0.03

Forward PEG 0.20

PS Ratio N/A

Forward PS 2.10

PB Ratio 2.71

P/FCF Ratio -5.06

P/Adj. FCF Ratio -4.79

P/OCF Ratio -5.00

EV/Sales N/A

EV/EBIT -4.36

EV/EBITDA -2.75

EV/FCF -3.17

Earnings Yield -19.0%

FCF Yield -19.8%

Adj. FCF Yield -20.9%

Financial Health

Net Cash $33.5M

Total Debt $511K

Cash & Short-Term Investments $34.01M

Total Assets $38.9M

Current Ratio 7.03

Quick Ratio 7.03

Debt / Equity Ratio 0.02

Debt / EBITDA -0.03

Debt / FCF -0.03

OCF / Debt -34.60

Interest Coverage -2,815.46

Altman Z-Score 1.61

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -5.7%

Returns

Return on Assets -43.1%

Return on Equity -50.2%

Return on Invested Capital -109.1%

Return on Capital Employed -109.4%

Return on Tangible Assets -43.1%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 62.0%

EPS CAGR 5Y 13.6%

EPS CAGR 10Y N/A

FCF CAGR 3Y 11.1%

FCF CAGR 5Y -14.5%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 7

EPS Growth Next 3Y -28.1%

Revenue Growth Next 3Y N/A

Earnings Date Nov 4, 2026

EPS Estimate (next Q) -$0.07

EPS Growth Est (next Q) 16.7%

Revenue Est (next Q) $5.3M

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $3

Price Target Upside 200.0%

Cash Flow

Operating Cash Flow $-17.68M

Free Cash Flow $-17.68M

Adj. Free Cash Flow $-18.69M

FCF Per Share -$0.20

OCF Per Share -$0.20

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-129K

Operating Income $-36.6M

EBITDA $-20.38M

Net Income $-12.84M

EPS (Diluted) -$0.19

Revenue / Employee N/A

Profit / Employee $-917.36K

Employees 14